Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy [5]

Bone Marrow Transplantation

Volumn 37, Issue 3, 2006, Pages 337-338

  Mateos, J ^a   Perez Simonn J A ^a,b   Caballero, D ^a   Castilla, C ^a   Lopez, O ^a   Perez, E ^a   Canizo C ^a,b   Vazquez, L ^a   San Miguel, J F ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Centro de Investigacion del Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HEMOGLOBIN; LACTATE DEHYDROGENASE; TSUKUBAENOLIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANEMIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOSE RESPONSE; DRUG RESPONSE; DRUG SUBSTITUTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOPENIA; MALE; NONHODGKIN LYMPHOMA; PLASMAPHERESIS; PRIORITY JOURNAL; SCHISTOSOMA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; FEMALE; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 33645309649     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705241     Document Type: Letter

References (10)

1. Daly AS, Hasegawa WS, Lipton H, Messner HA, Kiss TL. Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venooclusive disease of the liver. Transfus Apher Sci 2002; 27: 3-12.
2. Fuge R, Bird J, Fraser A, Hart D, Hunt L, Cornish J et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura ocurring after bone marrow transplantation. Br J Haematol 2001; 113: 58-64.
3. Llamas P, Romero R, Cabrera R, Sanjuan I, Forés R, Fernandez MN. Management of thrombotic microangiopathy following allogenic transplantation: What is the role of plasma exchange? Bone Marrow Transplant 1997; 20: 305-306.
4. Daly AS, Xenocostas A, Lipton JH. Transplantation-associated thrombotic microangiopathy: Twenty-two years later. Bone Marrow Transplant 2002; 30: 709-715.
5. Silva VA, Frei-Lahr D, Brown RA, Herzig GP. Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apher 1991; 6: 16-20.
6. Böhm M, Betz C, Miesbach W, Krause M, Von Auer C, Geiger H et al. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Br J Haematol 2005; 129: 644-652.
7. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS. Bone marrow transplant-associated thrombotic microangiopathy: A case series. Bone Marrow Transplant 1995; 15: 247-253.
8. Mayer S, Aledort L. Thrombotic microangiopathy: Differential diagnosis, pathophysiology and therapeutic strategies. Mount sinayi J Med 2005; 72: 166-175.
9. Ziman A, Mitri M, Klapper E, Pepkowitz SH, Goldfinger D. Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: One institution's experience and review of the literature. Transfus pract 2005; 45: 41-49.
10. Ferrara F, Annunziata M, Pollio F, Palmieri S, Copia C, Mele G et al. Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura. Am J Hematol 2002; 81: 7-10.